(Albany, US) DelveInsight has launched a new report on Acute Heart failure Epidemiology
DelveInsight’s ‘Acute Heart failure (AHF) – Epidemiology Forecast to 2030′ report delivers an in-depth understanding of the disease, historical and forecasted Acute Heart failure (AHF) epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Heart Failure (HF), also known as congestive HF, is bifurcated as left-side HF (when the heart is unable to pump enough oxygen in the blood to the body) and right-side HF (when the heart is unable to fill itself with enough blood). Acute heart failure (AHF) is broadly defined as a rapid onset of new or worsening signs and symptoms of HF. It is often a potentially life-threatening condition requiring hospitalization, and emergency treatment aim to manage fluid overload and hemodynamic compromise. This umbrella term includes patients presenting for the first time with typical symptoms and signs of heart failure (de novo AHF) and those with worsening of their pre-existing cardiomyopathy (acute decompensated heart failure).
View Free Sample Page:- https://www.delveinsight.com/sample-request/acute-heart-failure-ahf-epidemiology-forecast
Acute Heart failure Epidemiology
A less common precipitant to AHF is one of a several possible non-ischemia myocardial insults. This includes the onset of acute myocardial dysfunction with inflammatory insults, toxic insults, and insults of an undefined nature such as peripartum cardiomyopathy. Admission to hospital with AHF can often herald a diagnosis of chronic HF as these acute insults may have long-term sequelae on myocardial function. Acute HF severity can be measured using known predictors of poor outcome, such as hypotension, renal dysfunction, hyponatremia, elevated biomarkers, respiratory distress, or concomitant comorbidities. The large majority of patients presenting with AHF do so in the context of pre-existing cardiomyopathy, a situation described as acute decompensated heart failure (ADHF). There are several key differences between this group of patients and those presenting with de novo AHF. Unlike with de novo AHF, patients with ADHF tend to present with signs and symptoms of congestion and fluid retention (weight gain, exertional dyspnea, orthopnea, dependent edema) rather than with pulmonary edema or cardiogenic shock that characterize acute LV systolic dysfunction.
Acute Heart failure Key facts
Acute Heart failure Report Scope
Download Free Sample Page:- https://www.delveinsight.com/sample-request/acute-heart-failure-ahf-epidemiology-forecast
Table of content
1. Key Insights
2. Executive Summary of Acute Heart failure (AHF)
3. Acute Heart failure (AHF): Disease Background and Overview
4. Patient Journey
5. Epidemiology and Patient Population
6. Treatment Algorithm, Current Treatment, and Medical Practices
7. KOL Views
8. Unmet Needs
9. Appendix
10. DelveInsight Capabilities
11. Disclaimer
12. About DelveInsight
Why should you buy this report?
Related Reports
About Us
DelveInsight is a Business Consulting and Market research company, providing expert business solutions for life science vertical and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers & Acquisitions.
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Yash BhardwajEmail: Send EmailPhone: +919650213330Address:304 S. Jones Blvd #2432 City: Las VegasState: NVCountry: United StatesWebsite: https://www.delveinsight.com/